Acambis: Gordon Cameron Resigned as Company Secretary CAMBRIDGE, U.K., July 2, 2002 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM) (Nasdaq:ACAM) announced that, with effect from July 1, 2002, Gordon Cameron has resigned from his role as Company...

Acambis Plc: Preliminary Results for the Year Ended December 31, 2001 (with link) CAMBRIDGE, U.K., March 12, 2002 (PRIMEZONE) -- Acambis plc ("Acambis" or "the Company") (LSE:ACM) (Nasdaq:ACAM) announces its preliminary results for the year ended December 31,...

Acambis Plc: ChimeriVax-JE Vaccine Successfully Completes Second Phase II Trial CAMBRIDGE, U.K., Feb. 14, 2002 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM)(Nasdaq:ACAM) announces that it has successfully completed a second Phase II trial of its ChimeriVax-JE vaccine against...

Acambis plc: Proposed $40 Million Financing of the Canton Manufacturing Facility and Notice of Extraordinary General Meeting CAMBRIDGE, U.K., Dec. 5, 2001 (PRIMEZONE) -- Acambis plc ("Acambis") (LSE:ACM) (Nasdaq:ACAM) announces the arrangements to finance (the "Financing") the reactivation of its manufacturing facility in...